Disposition of LY333531, a selective protein kinase C β inhibitor, in the Fischer 344 rat and beagle dog

J. L. Burkey Lilly Research Laboratories, Division of Eli Lilly and Co., Lilly Corporate Center, Indianapolis, IN 46285, USA

K. M. Campanale Lilly Research Laboratories, Division of Eli Lilly and Co., Lilly Corporate Center, Indianapolis, IN 46285, USA

D. D. O'Bannon Lilly Research Laboratories, Division of Eli Lilly and Co., Lilly Corporate Center, Indianapolis, IN 46285, USA

J. W. Cramer Lilly Research Laboratories, Division of Eli Lilly and Co., Lilly Corporate Center, Indianapolis, IN 46285, USA

N. A. Farid Lilly Research Laboratories, Division of Eli Lilly and Co., Lilly Corporate Center, Indianapolis, IN 46285, USA

References

BREWER, E., VITALE, K., MANN, M., LOWES, S., HUMPHRIES, D., Li, Q., GARNER, C. O. and HENION, J. 1999. Determination of LY333531 and its desmethyl metabolite in plasma from multiple species by API LC/MS/MS. In Proceedings of the 47th American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics. Dallas, TX.
Google Scholar
DANIS, R. P., BINGAMAN, D. P., JIROUSEK, M. R. and YANG, Y., 1998, Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKC 13 inhibition with LY333531. Investigative Ophthalmology and Visual Science, 39, 171–179.
PubMed Web of Science ®Google Scholar
ISHH., JIROUSEK, M. R., KOYA, D., TAKAGI, C., XIA, P., CLERMONT, A., BURSELL, S.-E., KERN, T. S., BALLAs, L. M., HEATH, W. F., STRAMM, L. E., FEENER, E. P. and KING, G. L., 1996, Amelioration of vascular dysfunctions in diabetic rats by an oral PKC /I inhibitor. Science, 272, 728–731.
Google Scholar
KOWLURU, R., JIROUSEK, M., STRAMM, L., ENGERMAN, R. and KERN, T., 1996, Diabetes-induced disorders of retinal protein kinase C and Na,K-ATPase are inhibited by LY333531. Diabetes, 45(S2), 16A.
Google Scholar
KOWLURU, R. A., JIROUSEK, M. R., STRAMM, L. E., FARID, N. A., ENGERMAN, R. L. and KERN, T. S., 1998, Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C ATPases. Retinal protein kinase C in diabetes. Diabetes, 47, 464–469.
PubMed Web of Science ®Google Scholar
KOYA, D. and KING, G. L., 1998, Protein kinase C activation and the development of diabetic complications. Diabetes 47, 859–866.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Disposition of LY333531, a selective protein kinase C β inhibitor, in the Fischer 344 rat and beagle dog

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Disposition of LY333531, a selective protein kinase C β inhibitor, in the Fischer 344 rat and beagle dog

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date